Derrick Goodman

1.3k total citations
10 papers, 346 citations indexed

About

Derrick Goodman is a scholar working on Virology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Derrick Goodman has authored 10 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Virology, 8 papers in Infectious Diseases and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Derrick Goodman's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (3 papers). Derrick Goodman is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (3 papers). Derrick Goodman collaborates with scholars based in United States. Derrick Goodman's co-authors include Michael D. Miller, Evguenia S. Svarovskaia, Katyna Borroto–Esoda, Nicolas Margot, Kirsten White, Damian J. McColl, Lijie Zhong, Florence Myrick, Joy Y. Feng and Yun Zhou and has published in prestigious journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.

In The Last Decade

Derrick Goodman

10 papers receiving 342 citations

Peers

Derrick Goodman
Jason Isaacson United States
Axel Fun Netherlands
Alex Dusek United States
Nicole Espy United States
Derrick Goodman
Citations per year, relative to Derrick Goodman Derrick Goodman (= 1×) peers Gabrielle Heilek‐Snyder

Countries citing papers authored by Derrick Goodman

Since Specialization
Citations

This map shows the geographic impact of Derrick Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derrick Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derrick Goodman more than expected).

Fields of papers citing papers by Derrick Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derrick Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derrick Goodman. The network helps show where Derrick Goodman may publish in the future.

Co-authorship network of co-authors of Derrick Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Derrick Goodman. A scholar is included among the top collaborators of Derrick Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derrick Goodman. Derrick Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Adams, Lily E., Jaclyn S. Higgins, Kara Anasti, et al.. (2024). Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions. PLoS Pathogens. 20(6). e1011569–e1011569. 10 indexed citations
2.
Carpenter, Margaret C., Rachel L. Spreng, Scott D. Neidich, et al.. (2022). Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans. npj Vaccines. 7(1). 90–90. 7 indexed citations
3.
Edwards, Robert J., Celia C. LaBranche, Katayoun Mansouri, et al.. (2021). Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers. Frontiers in Immunology. 12. 670561–670561. 6 indexed citations
4.
Pollara, Justin, R. Whitney Edwards, Maria Dennis, et al.. (2019). Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models. Journal of Virology. 93(10). 16 indexed citations
5.
Andreatta, Kristen, Derrick Goodman, Michael D. Miller, & Kirsten White. (2015). Reduced Viral Fitness and Lack of Cross-Class Resistance with Integrase Strand Transfer Inhibitor and Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations. Antimicrobial Agents and Chemotherapy. 59(6). 3441–3449. 7 indexed citations
6.
Abram, Michael E., Derrick Goodman, Kristen Andreatta, et al.. (2013). Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness. Antimicrobial Agents and Chemotherapy. 57(6). 2654–2663. 94 indexed citations
7.
Goodman, Derrick, Yun Zhou, Nicolas Margot, et al.. (2010). Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy. AIDS. 25(3). 325–333. 73 indexed citations
8.
Feng, Joy Y., Florence Myrick, Derrick Goodman, et al.. (2009). The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study. Retrovirology. 6(1). 44–44. 54 indexed citations
9.
Svarovskaia, Evguenia S., Joy Y. Feng, Nicolas Margot, et al.. (2008). The A62V and S68G Mutations in HIV-1 Reverse Transcriptase Partially Restore the Replication Defect Associated With the K65R Mutation. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(4). 428–436. 48 indexed citations
10.
Svarovskaia, Evguenia S., Nicolas Margot, Andrew Bae, et al.. (2007). Low-Level K65R Mutation in HIV-1 Reverse Transcriptase of Treatment-Experienced Patients Exposed to Abacavir or Didanosine. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(2). 174–180. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026